BioHarvest Sciences Inc.

BioHarvest Sciences Inc.

BHST - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$28.76M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
BioHarvest Sciences Inc.BioHarvest Sciences Inc.-3.1--56%1.70.9
$5.00

Target Price by Analysts

201.2% upsideBioHarvest Sciences Target Price DetailsTarget Price

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$28.76 Million
Enterprise Value$30.50 Million
Earnings per Share$-0.6
Beta1.38
Outstanding Shares22,667,842

Return

Return on Equity-56.03%ROE
Return on Assets-24.84%
Return on Invested Capital-27.45%

Valuation & Multiples

P/E Ratio-3.07P/E Ratio
PEG34.36PEG
Price to Sales1.66Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue0.86
Enterprise Value to EBIT-3.38
Enterprise Value to Net Income-3
Total Debt to Enterprise0.59
Debt to Equity0.91Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 11, 2026
EPS Estimate
$-0.13
Consensus analyst estimate
Revenue Estimate
$9.45 M
Consensus analyst estimate

Next Earnings Call

Expected Date
November 12, 2026
EPS Estimate
$-0.16
Consensus analyst estimate
Revenue Estimate
$9.31 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %7.42%▼ 0.08%
Total Invested$4.80M▼ 34.94%
Investors Holding18▼ 2.00%

About BioHarvest Sciences Inc.

89 employees
CEO: Zaki Rakib

BioHarvest Sciences Inc. is a biotechnology company that operates through two segments: Products and CDMO Services. The company has developed a botanical synthesis platform technology to grow plant cells with higher concentrations of act...